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A B S T R A C T
Background
Effective synchronisation of infant respiratory effort with mechanical ventilation may allow adequate gas exchange to occur at lower
peak airway pressures, potentially reducing barotrauma and volutrauma and development of air leaks and bronchopulmonary dysplasia.
During neurally adjusted ventilatory assist ventilation (NAVA), respiratory support is initiated upon detection of an electrical signal
from the diaphragmmuscle, and pressure is provided in proportion to and synchronous with electrical activity of the diaphragm (EADi).
Compared to other modes of triggered ventilation, this may provide advantages in improving synchrony.
Objectives
Primary
• To determine whether NAVA, when used as a primary or rescue mode of ventilation, results in reduced rates of bronchopulmonary
dysplasia (BPD) or death among term and preterm newborn infants compared to other forms of triggered ventilation
• To assess the safety of NAVA by determining whether it leads to greater risk of intraventricular haemorrhage (IVH), periventricular
leukomalacia, or air leaks when compared to other forms of triggered ventilation
Secondary
• To determine whether benefits of NAVA differ by gestational age (term or preterm)
• To determine whether outcomes of cross-over trials performed during the first two weeks of life include peak pressure requirements,
episodes of hypocarbia or hypercarbia, oxygenation index, and the work of breathing
Search methods
We performed searches of the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cohrane Library; MEDLINE via
Ovid SP (January 1966 to March 2017); Embase via Ovid SP (January 1980 to March 2017); the Cumulative Index to Nursing and
Allied Health Literature (CINAHL) via EBSCO host (1982 to March 2017); and the Web of Science (1985 to 2017). We searched
abstracts from annual meetings of the Pediatric Academic Societies (PAS) (2000 to 2016); meetings of the European Society of Pediatric
Research (published in Pediatric Research); and meetings of the Perinatal Society of Australia and New Zealand (PSANZ) (2005 to
2016). We also searched clinical trials databases to March 2017.
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Selection criteria
We included randomised and quasi-randomised clinical trials including cross-over trials comparing NAVAwith othermodes of triggered
ventilation (assist control ventilation (ACV),synchronous intermittent mandatory ventilation plus pressure support (SIMV ± PS),
pressure support ventilation (PSV), or proportional assist ventilation (PAV)) used in neonates.
Data collection and analysis
Primary outcomes of interest from randomised controlled trials were all-cause mortality, bronchopulmonary dysplasia (BPD; defined
as oxygen requirement at 28 days), and a combined outcome of all-cause mortality or BPD. Secondary outcomes were duration of
mechanical ventilation, incidence of air leak, incidence of IVH or periventricular leukomalacia, and survival with an oxygen requirement
at 36 weeks’ postmenstrual age.
Outcomes of interest from cross-over trials were maximum fraction of inspired oxygen, mean peak inspiratory pressure, episodes of
hypocarbia, and episodes of hypercarbia measured across the time period of each arm of the cross-over. We planned to assess work of
breathing; oxygenation index, and thoraco-abdominal asynchrony at the end of the time period of each arm of the cross-over study.
Main results
We included one randomised controlled study comparing NAVA versus patient-triggered time-cycled pressure-limited ventilation. This
study found no significant difference in duration of mechanical ventilation, nor in rates of BPD, pneumothorax, or IVH.
Authors’ conclusions
Risks and benefits of NAVA compared to other forms of ventilation for neonates are uncertain. Well-designed trials are required to
evaluate this new form of triggered ventilation.
P L A I N L A N G U A G E S U M M A R Y
Neurally adjusted ventilatory assist for neonatal respiratory support
Review question: Is neurally adjusted ventilatory assist ventilation (NAVA) a more effective method of supporting the breathing of
prematurely born infants than conventional ventilation methods?
Background: Neurally adjusted ventilatory assist involves using the electrical signal from the baby’s main breathing muscles to inform
the ventilator as to when the baby is trying to breathe, such that the ventilatory may support the baby’s own efforts. Synchronising the
efforts of the infant with the activity of the ventilator may reduce required pressures required, along with damage to the lungs. Using
the baby’s own breathing control mechanisms may also reduce fluctuations in carbon dioxide levels in the blood and variations in blood
flow to the brain.
Study characteristics: During literature searches completed until March 2017, we found one randomised controlled study that met
the inclusion criteria for this review.
Key results: We found one eligible study that was conducted to evaluate the use of NAVA in providing neonatal respiratory support.
This study reported no significant differences in outcomes of interest between NAVA and patient-triggered time-cycled pressure-limited
ventilation. Well-designed studies are needed to further evaluate the role of this potentially exciting technique in providing breathing
support for the neonatal population.
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B A C K G R O U N D
Despite improved survival rates among preterm infants, the in-
cidence of ventilator-related complications remains high. In par-
ticular, the incidence of bronchopulmonary dysplasia (BPD) has
been unchanged over the past two decades (Costeloe 2012).
Bronchopulmonary dysplasia has been defined in various ways.
The National Institute of Child Health and Human Develop-
ment (NICHD), the National Heart, Lung and Blood Institute
(NHLBI), and theOffice of RareDisease ResearchWorkshop have
defined BPD as oxygen dependency at 28 days of life (Jobe 2001),
and have further subdivided infants at 36 weeks’ postmenstrual
age (PMA) as to whether they have mild BPD (no longer oxygen
dependent), moderate BPD (with oxygen requirement < 30%), or
severe BPD (with oxygen requirement > 30%; or requirement for
continuous positive airway pressure (CPAP) or mechanical venti-
lation). Oxygen dependency at 36 weeks’ PMA is also widely used
as a definition of BPD.
Bronchopulmonary dysplasia has a multi-factorial origin that in-
cludes oxygen toxicity and volutrauma. Pneumothorax is another
important ventilator-related complication, as it often precedes in-
tracerebral haemorrhage in prematurely born infants. Pneumoth-
oraces occur in infants whose respiratory efforts are asynchronous
with mechanical inflations as they actively expire (Greenough
1984a). In contrast, infants whose respiratory efforts are syn-
chronous with mechanical ventilation have improved oxygena-
tion and do not develop pneumothoraces. Synchrony can be
achieved with fast rates (≥ 60 breaths per minute (bpm)) or pa-
tient-triggered ventilation (Greenough 1986). A Cochrane Re-
view compared methods of improving synchronisation using fast
rates (60 to 120 bpm), high-frequency positive-pressure ven-
tilation (HFPPV), or patient-triggered ventilation (assist con-
trol ventilation (ACV) or synchronous intermittent mandatory
ventilation (SIMV)) versus conventional mechanical ventilation
(CMV) (Greenough 2008). Meta-analysis demonstrated that HF-
PPV when compared to CMV was associated with reduced risk of
air leak, and that patient-triggered ventilation when compared to
CMV was associated with a shorter duration of ventilation, but
that no significant reduction in BPD occurred when either mode
was used to improve synchrony.
During ACV and SIMV, ventilation is triggered by pressure or
flow sensors, which determine when inflation is initiated. In the
neonatal population with small tidal volumes, high respiratory
rates, and often significant leak from uncuffed endotracheal tubes,
sensitive triggering can be challenging, and hence some of the ben-
efits of triggered ventilation may not materialise. During neurally
adjusted ventilatory assist (NAVA), the electrical activity of the di-
aphragm, detected via electrodes on a modified nasogastric tube,
enables both the start and the end of an inflation to be synchro-
nised with the infant’s respiratory effort. Indeed, by using NAVA,
respiratory support can be tailored throughout to match the in-
fant’s respiratory cycle. Thus, it is likely that NAVA may provide
superior support compared to other forms of triggered ventilation.
In this review, we will evaluate whether evidence shows short-term
and long-term benefits of NAVA over other methods of triggered
ventilation in the neonatal population.
Description of the condition
Most neonates breathe duringmechanical ventilation. Asynchrony
occurs when the ventilator delivers mechanical support out of
phase with the respiratory efforts of the infant. In a study of
34 infants undergoing mechanical ventilation, eight infants who
went on to develop pneumothoraces were found to actively exhale
against a ventilator inflation (Greenough 1983). In a randomised
controlled trial (RCT), investigators randomised preterm venti-
lated infants with asynchrony to paralysis with pancuronium or
to no paralysis. Pneumothoraces developed in all 11 unparalysed
infants, but in none of those randomised to paralysis (Greenough
1984b). Asynchrony may predispose to other morbidity. Perl-
man found an association between fluctuations in cerebral blood
flowand subsequent development of intraventricular haemorrhage
(IVH). Fluctuations in cerebral blood flow and both the inci-
dence and the severity of IVH were reduced with muscle paralysis
(Perlman 1985). Synchronisation of respiratory effort with venti-
lator inflation reduces asynchrony and is associated with improved
oxygenation and carbon dioxide elimination (Donn 2003). Syn-
chronisation of inspiratory efforts with positive-pressure inflations
should therefore result in adequate ventilation using lower infla-
tion pressures and should reduce the risk of lung injury by volu-
trauma or hyperoxia.
Description of the intervention
Several modes of triggered ventilation have been used in the neona-
tal population and will be considered in this systematic review.
Both ACV and SIMV deliver breaths triggered by the infant’s res-
piratory effort, with the former supporting all breaths that are
greater than the critical trigger level, and the latter supporting only
the number of breaths set by the practitioner (breaths above that
preset number are not supported by positive-pressure inflations).
During ACV and SIMV, inflations can be pressure limited or vol-
ume targeted. During volume-targeted ventilation, a prespecified
volume is delivered to the infant regardless of changes in lung func-
tion. In both modes, timing of the onset of inflation is determined
by the infant’s inspiratory efforts but inflation is terminated when
the set inflation time is reached. Patient-triggered ventilation has
usually relied on flow or pressure changes to trigger inspiration.
The infant must initiate a sufficient change in pressure or flow to
trigger ventilator support, and this may result in delay in deliv-
ery of an inflation (trigger delay), increasing the infant’s work of
breathing. In contrast, during pressure support ventilation (PSV),
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both the beginning and the end of inflation are determined by the
infant’s inspiratory efforts, reducing the likelihood of asynchrony
(Dimitriou 1998). During proportional assist ventilation (PAV),
applied pressure is servo controlled throughout each spontaneous
breath and is increased in proportion to the tidal volume and flow
generated by the infant. Frequency, timing, andmagnitude of lung
inflation are controlled by the infant.
Similarly, NAVA provides respiratory support throughout the in-
fant’s respiratory cycle, but the electrical activity of the diaphragm
is used to ’control’ respiratory support. This technique has been
successfully used in very low birth weight infants weighing as little
as 640 grams (Beck 2009). Diaphragmatic activity is determined
by assessing the electrical activity of the diaphragm (EAdi) using
a series of electrodes mounted on a modified nasogastric feeding
tube.
How the intervention might work
Changes in electrical activity in the diaphragm at the beginning
of inspiration precede changes in pressure and flow, hence NAVA
may have a shorter trigger delay than other modes of triggered
ventilation. During NAVA, termination of inflation is also con-
trolled by the EAdi signal, hence asynchrony is less likely to occur.
Reduction in asynchrony may result in a lower incidence of pneu-
mothoraces and intracerebral haemorrhage. Improved synchroni-
sation could improve oxygenation and carbon dioxide clearance.
Furthermore, respiratory support through the infant’s respiratory
cycle is likely to be more effective as demonstrated during PAV,
with a reduction in the oxygenation index (Bhat 2015), and during
NAVA, effective ventilation could be achieved at lower pressures
or volumes.
Why it is important to do this review
Patient-triggered ventilation should reduce respiratory morbid-
ity among neonates by improving synchronisation, but results of
RCTs to date have yielded limited positive results. NAVA is a more
sophisticated form of PTV that has been developed recently for
neonates. To our knowledge, no systematic reviews have evaluated
the use of this modality in the neonatal population; hence, it is
important to assess the benefits of NAVA versus other triggered
modes.
O B J E C T I V E S
Primary
• To determine whether NAVA, when used as a primary or
rescue mode of ventilation, results in reduced rates of
bronchopulmonary dysplasia (BPD) or death among term and
preterm newborn infants compared to other forms of triggered
ventilation
• To assess the safety of NAVA by determining whether it
leads to greater risk of intraventricular haemorrhage,
periventricular leukomalacia, or air leaks when compared to
other forms of triggered ventilation
Secondary
• To determine whether benefits of NAVA differ by
gestational age (term or preterm)
• To determine whether outcomes of cross-over trials
performed during the first two weeks of life include peak
pressure requirements, episodes of hypocarbia or hypercarbia,
oxygenation index, and the work of breathing
M E T H O D S
Criteria for considering studies for this review
Types of studies
Weconsidered randomised andquasi-randomised, but not cluster-
randomised, controlled studies. For RCTs evaluating NAVA as the
primary mode of ventilation, randomisation must have occurred
within 24 hours of birth. If randomisation occurred after 24 hours
but within 28 days, the study may be included to evaluate NAVA
as a rescue mode of ventilation.
We also considered cross-over studies, if they occurred within 28
days of birth with a minimum study period of one hour on each
intervention. We included studies even if they did not report all
outcomes of interest.
Types of participants
Infants born at term and preterm infants requiring mechanical
ventilation and studied at a postmenstrual age of less than 44
weeks.
Types of interventions
• NAVA - delivered via an endotracheal tube with
diaphragmatic electromyography (EMG) used as the trigger
device versus other triggered modes
◦ Synchronised intermittent mandatory ventilation
(SIMV) (either pressure limited or volume targeted)
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◦ Assist control ventilation (ACV) (either pressure
limited or volume targeted)
◦ SIMV or ACV with pressure support
◦ PAV
• NAVA compared to “control” interventions as
◦ Primary mode of ventilation (randomised within 24
hours of birth)
◦ Rescue mode (randomised after 24 hours, following
any other mode of ventilation)
We considered studies in which ventilation was delivered by a
trigger mode; any differences in outcome attributable to trigger
mode were considered as part of the subgroup analysis.
Types of outcome measures
Primary outcomes
• All-cause mortality
• Bronchopulmonary dysplasia defined as an oxygen
requirement at 36 weeks’ postmenstrual age for infants of less
than 32 weeks’ gestational age, and defined as an oxygen
requirement at 28 days’ postmenstrual age for infants of more
than 32 weeks’ gestational age (Jobe 2001)
• All-cause mortality or bronchopulmonary dysplasia as
previously defined
Secondary outcomes
• Duration of mechanical ventilation (days)
• Incidence of air leak: pneumothorax or pulmonary
interstitial emphysema (PIE) (study author defined)
• Incidence of intracerebral haemorrhage or periventricular
leukomalacia
• Survival with an oxygen requirement at 36 weeks’
postmenstrual age
Outcomes of cross-over trials assessed during each of the study
periods:
• Maximum fraction of inspired oxygen (FiO2)
• Mean peak inspiratory pressures (cm H2O)
• Episodes of hypocarbia (pCO2 < 35 mmHg) defined as any
episode during the study period
• Episodes of hypercarbia (PaCO2 > 60 mmHg) defined as
any episode during the study period
At the end of each period on each comparator ventilation mode:
• Work of breathing (transdiaphragmatic pressure time
product/cm H2O.seconds/minute)
• Oxygenation index ((FiO2 × mean airway pressure)/PaO2)
• Thoraco-abdominal asynchrony using respiratory
inductance bands (phase angle/degrees)
pCO2: partial pressure of carbon dioxide
PaCO2: partial pressure of carbon dioxide in arterial blood
PaO2: partial pressure of oxygen in arterial blood
Search methods for identification of studies
We used the standard search strategy of the Cochrane Neonatal
Group.
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 2) in the Cochrane Library; MEDLINE
via Ovid SP (January 1966 to 26 March 2017); Embase via Ovid
SP (January 1980 to 26 March 2017); the Cumulative Index to
Nursing and AlliedHealth Literature (CINAHL) via EBSCOhost
(1982 to 26March 2017); andWeb of Science (1985 to 26March
2017). In addition, we searched abstracts from annual meetings
of the Pediatric Academic Societies (PAS) (2000 to 2016); meet-
ings of the European Society of Pediatric Research published in
Pediatric Research; and meetings of the Perinatal Society of Aus-
tralia and New Zealand (PSANZ) (2005 to 2016). We used the
Cochrane highly sensitive search strategy for identifying RCTs, as
suggested in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011).We used the following medical subject
headings (MeSH): infant, newborn AND Interactive Ventilatory
Support AND the text word “neurally adjusted” or “NAVA”. We
performed a second search using the following MeSH headings:
infant, newborn AND text word “neurally adjusted” OR “NAVA”.
We combined results of the two searches and applied no restric-
tions on date, language, or publications.
Searching other resources
In addition, we searched the following registries.
• http://www.controlled-trials.com.
• http://clinicaltrials.gov.
• http://www.anzctr.org.au.
• http://www.who.int/ictrp/en/.
We checked the reference lists of all identified studies for further
relevant studies and searched conference abstracts for relevant un-
published studies.
Data collection and analysis
Selection of studies
Two review authors (TR, KH) undertook the study selection pro-
cess, independently identified studies, and assessed whether inclu-
sion criteria were fulfilled. We resolved disagreements by consul-
tation with another review author (AG).
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We have listed details of all excluded studies along with reasons
for exclusion in the Characteristics of excluded studies table.
Data extraction and management
Two review authors (TR, KH) independently extracted data using
a standardised form and resolved discrepancies by discussion and
when necessary by consultation with another review author (AG).
Assessment of risk of bias in included studies
Two review authors (TR, KH) independently assessed risk of bias
using the Cochrane domain-based tool for assessing risk of bias.
We scored selection bias, performance bias, detection bias, attri-
tion bias, reporting bias, and other bias. We rated overall risk of
bias for each study as ’high’, ’low’, or ’unclear’ according to guid-
ance provided in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). We resolved disagreements by con-
sensus or when necessary by discussion with another review author
(AG).
We assessed the following risk of bias domains.
• Sequence generation (selection bias).
• Allocation concealment (selection bias).
• Blinding of participants and personnel (performance bias).
• Blinding of outcome assessment (detection bias).
• Incomplete outcome data (attrition bias).
• Selective reporting (reporting bias).
• Any other bias.
One review author (TR) entered data into Review Manager soft-
ware, and a second review author (KH) verified the data (RevMan
2014). See Appendix 1 for a more detailed description of risk of
bias for each domain.
Measures of treatment effect
We planned to extract categorical data for each intervention group
and to calculate the risk ratio (RR) and the risk difference (RD). If
the RDwas statistically significant, wewould calculate the number
needed to treat for an additional beneficial (NNTB) or harmful
outcome (NNTH). We intended to report each continuous out-
come as a weighted mean difference (WMD) with a 95% confi-
dence interval (CI)
Analysis of cross-over trials depended on the risk of carry-over or
period effects. Were these not considered a problem, we planned
to calculate an effect estimate using the generic inverse variance
method provided in RevMan (Higgins 2011). If data were insuffi-
cient to include a paired analysis within a meta-analysis, we would
treat data as two parallel arms, acknowledging the loss of statistical
power.
Unit of analysis issues
When data available from cross-over trials were insufficient to
incorporate paired data in a meta-analysis, we would consider the
measurements from each arm separately as if they were derived
from a parallel-group trial. As this can result in a unit of analysis
error, wewould have included the results if theywere demonstrably
similar to the results of a paired analysis (Higgins 2011).
Dealing with missing data
Whenwe noted apparently missing data, we would have contacted
trial authors when possible. When data were missing from one
period of a cross-over trial, we planned to exclude data from both
periods from analysis.
Assessment of heterogeneity
We would have quantified heterogeneity using the I2 statistic, cal-
culated as described in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011). Thresholds for interpreting
I2 would include the following.
• 0% to 25%: no heterogeneity.
• 25% to 49%: low heterogeneity.
• 50% to 74%: moderate heterogeneity.
• ≥ 75%: high heterogeneity.
Were I2 to equal or exceed 75%, we would have conducted a
sensitivity analysis to explain the source of heterogeneity.
Assessment of reporting biases
Had we identified at least 10 trials for inclusion in a meta-analysis,
we would have created a funnel plot to assess publication bias.
Data synthesis
Were sufficient eligible studies available, wewould have performed
meta-analysis in RevMan using a fixed-effectmodel whenwe iden-
tified two or more RCTs with comparable populations and treat-
ment interventions. We would consider RCTs to be comparable
if investigators used NAVA as the primary mode of ventilation or
in a discreet analysis as rescue mode.
We would have presented our results with 95% CIs. When inves-
tigators used different scales to measure the same continuous data
between trials, we would have calculated standardised mean dif-
ferences (SMDs). For continuous data, we would have extracted
means and standard deviations and would have performed analy-
sis using weightedmean differences (WMDs).When investigators
measured outcomes using differing scales, we would have used
SMDs.
We would have assessed WMDs, RRs, and RDs and would have
analysed outcomes of comparable trials using 95% CIs to estimate
treatment effect. If appropriate, we would have compared results
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using forest plots, with the RR as the point estimate for dichoto-
mous outcomes, and WMD as the point estimate for continuous
outcomes.
Quality of evidence
We planned to use the GRADE approach, as outlined in the
GRADE Handbook (Schünemann 2013), to assess the quality of
evidence for the following (clinically relevant) outcomes.
• All-cause mortality.
• Bronchopulmonary dysplasia defined as an oxygen
requirement at 36 weeks’ postmenstrual age for infants of less
than 32 weeks’ gestational age, and at 28 days’ postmenstrual age
for more mature infants.
• All-cause mortality or BPD as previously defined.
Review authors planned to independently assess the quality of ev-
idence for each of the outcomes above. We planned to consider
evidence from RCTs as high quality but to downgrade evidence
one level for serious (or two levels for very serious) limitations
based upon the following: design (risk of bias), consistency across
studies, directness of evidence, precision of estimates, and pres-
ence of publication bias. We planned to use the GRADEproGDT
Guideline Development Tool to create a ‘Summary of findings’
table to report the quality of evidence (GRADEpro GDT).
The GRADE approach results in an assessment of the quality of
a body of evidence according to one of four grades.
• High: We are very confident that the true effect lies close to
that of the estimate of the effect.
• Moderate: We are moderately confident in the effect
estimate: The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low: Our confidence in the effect estimate is limited: The
true effect may be substantially different from the estimate of the
effect.
• Very low: We have very little confidence in the effect
estimate: The true effect is likely to be substantially different
from the estimate of effect.
Subgroup analysis and investigation of heterogeneity
We would have performed subgroup analysis as follows.
• Gestational age category: term (≥ 37 weeks’ gestational age)
or preterm (< 37 weeks’ gestational age).
• Type of triggered ventilation: ACV, SIMV or ACV, SIMV +
PSV, PAV.
Sensitivity analysis
If we identified sufficient studies, we would have performed a sen-
sitivity analysis to evaluate the robustness of results and to investi-
gate any source of heterogeneity.Wemay have performed sensitiv-
ity analysis by separating studies according to risk of bias in each of
the previously specified domains. We may have used a sensitivity
analysis particularly in evaluating data from cross-over studies to
determine the effect of including data from both study periods.
R E S U L T S
Description of studies
Results of the search
We recovered 191 records using the search technique. With re-
moval of duplicates, this corresponded to 177 studies. Follow-
ing primary screening, we reviewed 17 full-text articles and ex-
cluded 16 studies. We have listed reasons for exclusion in the
Characteristics of excluded studies table and have discussed these
reasons below. We included one RCT that evaluated use of NAVA
as a rescue mode of ventilation (see Characteristics of included
studies).
Included studies
The study selection process initially yielded no eligible studies.
Kallio 2016was excluded as randomisationwas performed in some
cases after 24 hours of age. Following discussion, the eligibility
criteria were revisited and the study was subsequently included as
it fulfilled the criteria for inclusion as a rescue therapy rather than
as an evaluation of NAVA as a primary mode of ventilation.
We identified only one RCT (Kallio 2016) that was eligible for
inclusion. This well-designed RCT randomised 60 prematurely
born infants toNAVAor pressure-controlled triggered ventilation.
Randomisation did not occur within 24 hours in many cases;
therefore, we included the study as an evaluation of NAVA as a
mode of rescue ventilation. Investigators reported no significant
differences between modes of ventilation with regards to duration
of mechanical ventilation and rates of BPD, pneumothorax, or
IVH. They reported lower peak inspiratory pressures in theNAVA
group than in groups given control methods of ventilation (see
Characteristics of included studies).
Excluded studies
We detected 16 studies that we found to be not eligible for inclu-
sion in the review (see Characteristics of excluded studies).
We excluded five studies as they were retrospective reviews or case
control studies (Guichoux 2011; Lee 2017; Maroszynska 2013;
Piastra 2014; Rahmani 2015). One was an observational study
in which four infants with congenital diaphragmatic hernia were
ventilated with NAVA (Guichoux 2011). We excluded this study
in the absence of a comparison arm. Another excluded trial was
a retrospective review of medical records (Lee 2017). We also ex-
cluded a review of eight prematurely born infants ventilated with
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NAVA with no control arm (Maroszynska 2013). We excluded a
case control study that compared 10 infants ventilated with NAVA
versus 20 infants ventilated with PSV (Piastra 2014). In addition,
we excluded a retrospective notes review of seven preterm infants
(Rahmani 2015).
We excluded nine cross-over studies. Seven of these were not ran-
domised (Beck 2009; Colombo 2011; Grassino 2011; Grassino
2011a; Bordessoule 2012; Stein 2013; Longhini 2015). The two
randomised cross-over trials studied infants after 28 days of age in
some cases (Lee 2012; Shetty 2017).
In one excluded study, investigators included seven infants ini-
tially given conventional triggered ventilation, then transferred
onto NAVA (Beck 2009). They reported improved patient-venti-
lator interaction. We excluded this study as study authors reported
no randomisation of the order in which modes were delivered,
and one of the seven infants was over two weeks of age at the time
of the study. We excluded a non-randomised cross-over trial that
included eight preterm infants with acute respiratory distress in
a comparison with pressure-regulated volume-controlled ventila-
tion (Colombo 2011). Researchers reported that NAVA was as-
sociated with fewer high-volume breaths (> 8 mL/kg) but noted
no significant differences on blood gas analysis. We excluded this
study because infants were studied in a non-randomised sequence.
In another trial, investigators studied eight preterm infants who
were given SIMV, then NAVA, and showed lower peak inspira-
tory pressure (PIP) on NAVA (Grassino 2011). As study authors
provided no randomisation of sequence, we excluded this study.
These same investigators later studied 10 preterm infants given
SIMV, then NAVA, and reported lower PIP on NAVA (Grassino
2011a). We excluded this study in view of non-randomisation of
the sequence in which infants were studied. It is probable that this
study shared participants and data with the 2011 study (Grassino
2011).
Bordessoule studied 10 infants givenbothNAVAand conventional
triggered ventilation (Bordessoule 2012). We excluded this study
because all infantswere outside the neonatal period and trialists did
not randomise the order of ventilation mode.We identified a non-
randomised cross-over study including five premature infants in
which investigators reported lower PIP, respiratory rate, and end-
tidal CO2 during theNAVAperiod (Stein 2013).We excluded this
study as the sequence of the studywas non-randomised and infants
were studied after two weeks of age in many cases. Another non-
randomised cross-over study included 14 prematurely born infants
who receivedPRVCventilationfirst, thenNAVA (Longhini 2015).
Investigators reported less asynchrony on NAVA. However, as the
sequence of ventilation modes was not randomised, we excluded
this study.
We identified a well-designed randomised cross-over study that
compared NAVA versus SIMV with pressure support (Lee 2012).
Study authors found lower PIP with NAVA.However, as measure-
ments were performed after 28 days of age inmany cases, this study
did not fulfil the inclusion criteria of this review. Another well-
designed randomised cross-over study of nine prematurely born
infants compared NAVA versus ACV (Shetty 2017). However, as
some infants were studied after 28 days, this study did not meet
the inclusion criteria for this review.
We found one ongoing study that is eligible and added it to the list
of ‘ongoing studies’. We added another study to the list of ‘studies
awaiting classification’, as it is reported as complete but has yielded
no publication (Figure 1).
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Figure 1. Study flow diagram.
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Risk of bias in included studies
We included one randomised controlled study (Kallio 2016). We
discuss risk of bias below.
Allocation
Investigators used a computer-generated randomisation code in
sealed opaque envelopes, which were allocated after written con-
sent had been obtained. We deemed this study to have low risk.
Blinding
Researchers undertook no blinding. Therefore, we considered
these domains to introduce high risk.
Incomplete outcome data
Study authors reported outcome data for all participants. There-
fore, we considered the study to be at low risk for this domain.
Selective reporting
Investigators reported all outcomes that were specified in the reg-
istered protocol. We considered this to introduce low risk.
Other potential sources of bias
We identified no other potential sources of bias.
Effects of interventions
We identified one study that was eligible for inclusion in this sys-
tematic review (Kallio 2016). Study authors reported no signifi-
cant differences in duration of mechanical ventilation, nor in rate
of BPD, pneumothorax, or IVH, between NAVA and patient-
triggered time-cycled pressure-limited ventilation. They reported
lower peak inspiratory pressures in the NAVA arm..
D I S C U S S I O N
Synchronisation of infant respiratory effort with mechanical ven-
tilation has been the objective of numerous ventilation strategies.
Triggered ventilation, conventionally driven by flow or pressure
sensors, has been shown to improve tidal volume and oxygena-
tion; however, impact on long-term outcomes such as bronchopul-
monary dysplasia (BPD) remains unclear. Neurally adjusted ven-
tilatory assist ventilation (NAVA) allows the infant to initiate sup-
port of inspiration and termination of inspiration, potentially al-
lowing efficient ventilation at lower pressures. Furthermore, using
the respiratory drive of the infant to control ventilation may help
avoid hypocarbia and hypercarbia.
Use of NAVA for infants requiring mechanical ventilation is in
its infancy. We found two randomised cross-over trials (Lee 2012;
Shetty 2017) including a total of 35 infants that compared NAVA
versus other modes of triggered ventilation in this population;
however some included infants were beyond four weeks of age,
leading to exclusion of these studies from this review. Cross-over
trials allow assessment of short-term physiological parameters but
not of long-term outcomes related to mode of ventilation. Al-
though no safety issues have been highlighted in the course of these
small studies, we cannot assess safety outcomes derived using this
trial design.
We identified one randomised controlled trial that compared
NAVA versus conventional triggered ventilation in the neonatal
population (Kallio 2016). This study reported lower peak inspira-
tory pressure (PIP) in the NAVA group than in the control group.
As many infants were randomised beyond 24 hours of age, this
study was eligible for inclusion in this review as investigators ex-
amined a rescue mode of ventilation. This study demonstrated
no significant differences between the two modes of ventilation
in the outcomes relevant to this review: duration of mechanical
ventilation, mortality, BPD, intraventricular haemorrhage (IVH),
and pneumothorax. Investigators reported lower peak inspiratory
pressures delivered by NAVA compared with assist control venti-
lation (ACV).
Well-designed randomised controlled trials comparing NAVA ver-
sus other modes of triggered ventilation in the neonatal popula-
tion are required to evaluate the safety and potential benefits of
this novel mode of ventilation.
Summary of main results
Only one study was eligible for inclusion (Kallio 2016). Investiga-
tors demonstrated no significant difference in rates of BPD, pneu-
mothorax, or IVH between infants ventilated with NAVA and
those given pressure-limited triggered ventilation. Resuls show no
significant difference in the duration of mechanical ventilation.
Overall completeness and applicability of
evidence
We found insufficient data to justify comment on the safety or
long-term outcomes of NAVA compared to other methods of trig-
gered ventilation.
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Quality of the evidence
We included one good quality randomised controlled study with
potential for bias as it was unblinded (Kallio 2016). Randomisa-
tion occurred after 24 hours in some cases; therefore researchers
could not evaluate use of NAVA as the primary mode of ventila-
tion.
Potential biases in the review process
We carried out this review with one deviation from the published
protocol: We considered cross-over studies as eligible if investi-
gators studied infants within 28 days from birth rather than 14
days, as specified in the protocol. This did not affect review out-
comes. Two review authors carried out searches independently and
showed good agreement.
Agreements and disagreements with other
studies or reviews
.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The risks and benefits of neurally adjusted ventilatory assist venti-
lation (NAVA) compared to other forms of ventilation for neonates
remain uncertain. The one randomised controlled study that was
eligible for inclusion in this review reported no significant differ-
ence in the outcomes of interest. Well-designed trials evaluating
this new form of triggered ventilation are required.
Implications for research
Several case series and non-randomised cross-over studies have
suggested a physiological benefit associated with NAVA compared
to other forms of triggered ventilation in the neonatal population.
Additional well-constructed randomised controlled trials are re-
quired to explore the important outcomes of death, bronchopul-
monary dysplasia, and intraventricular haemorrhages whenNAVA
is used as a primary mode of ventilation, or as a clearly defined
rescue therapy.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Kallio 2016
Methods Randomised controlled study
Participants Prematurely born infants born at between 28 and 37 weeks’ gestation who required
invasive ventilation for at least 4 hours owing to respiratory distress syndrome. We
excluded neonates with a known defect of the diaphragm and those who were unable to
receive a nasogastric or orogastric tube owing to congenital anomalies, alongwith patients
with severe perinatal asphyxia (pH < 7.0 or signs of hypoxic-ischaemic encephalopathy)
or known chromosomal abnormalities
Interventions Neurally adjusted ventilatory assist ventilation (NAVA) vs patient-triggered time-cycled
pressure-controlled ventilation, both delivered using Servo-i (Maquet Nordic, Solna,
Sweden)
Outcomes Mortality, peak inspiratory pressure, duration of ventilation, bronchopulmonary dyspla-
sia (BPD) at 36 weeks’ postmenstrual age, pneumothoraces, intraventricular haemor-
rhage (IVH)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised random number generator used, with
sealed opaque envelopes
Allocation concealment (selection bias) Low risk As above, allocated after written consent obtained
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding possible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Some infants did not receive NAVA for the entire study
for technical reasons
Selective reporting (reporting bias) Low risk All outcomes specified in the registered protocol were
reported
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Beck 2009 Seven infants; not randomised
Bordessoule 2012 Not randomised; postneonatal infants
Chen 2013 Unable to obtain translation; therefore unable to ascertain whether this study fulfilled inclusion criteria
Clement 2011 Not neonatal; not randomised
Colombo 2011 Non-randomised cross-over study
Grassino 2011 Non-randomised cross-over study
Grassino 2011a Non-randomised cross-over study
Guichoux 2011 Case series
Lee 2012 Some infants enrolled after 28 days
Lee 2017 Retrospective case review
Longhini 2015 Non-randomised trial
Maroszynska 2013 Case series
Piastra 2014 Case control; non-randomised trial
Rahmani 2015 Retrospective study
Shetty 2017 Some infants enrolled after 28 days
Stein 2013 Non-randomised cross-over study
Characteristics of studies awaiting assessment [ordered by study ID]
NCT01156467
Methods Neurally Adjusted Ventilatory Assist (NAVA) in Ventilatory Care of Premature Infants
Randomised controlled trial
Participants All children of postconceptional age from 28 + 0 to 36 + 6 weeks needing mechanical ventilation for at least 60
minutes
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NCT01156467 (Continued)
Interventions Control: Infants randomised to this armwill receive a regular nasogastric tube and routine ventilatory care. Ventilation
with i-Servo or Stephanie
NAVA Infants randomised to this arm will receive an Edi-catheter as an oro-/nasogastric tube; the Edi-signal will be
monitored and when possible NAVA ventilation used
Device: neurally adjusted ventilatory assist, i-Servo, Maquet Nordic (Solna, Sweden)
Outcomes Duration of mechanical ventilation, complications associated with mechanical ventilation
Notes ClinicalTrials.gov Identifier: NCT01156467
Contact person: Merja Ålander
University Hospital of Oulu, Oulu, Pohjois-Pohjanmaa, Finland 90100
Characteristics of ongoing studies [ordered by study ID]
Greenough 2016
Trial name or title Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation
Methods Randomised cross-over study
Participants Born at less than 32 weeks’ gestation and ventilated after 1 week of life
Interventions Ventilation with neurally adjusted ventilatory assist (NAVA) or proportional assist ventilation (PAV)
Outcomes Oxygenation index (OI)
Starting date November 2016
Contact information Anne Greenough, MD, FRCPCH, King’s College London
Notes ClinicalTrials.gov Identifier: NCT02967549
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D A T A A N D A N A L Y S E S
This review has no analyses.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We have increased the eligibility period for cross-over studies, including those performed up to 28 days after birth.
While not a deviation from protocol, a study excluded during the initial searches by TR and KH was subsequently included following
discussion and reinterpretation of the inclusion criteria. While not fulfilling the eligibility criteria for inclusion as a study evaluating
NAVA as a primary mode of ventilation as randomisation occurred in some cases after 24 hours of age, Kallio 2016 was included as a
study evaluating NAVA as a rescue mode of ventilation.
We have added methods and plans for ’Summary of findings’ tables and GRADE recommendations, which were not included in the
original protocol.
17Neurally adjusted ventilatory assist compared to other forms of triggered ventilation for neonatal respiratory support (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
